Added to Your Shopping Cart
Certificate of Analysis
Are you looking for...
You might be interested in...
Type in Product name, Keyword or Catalog number to see suggestions.
Need help? Please contact us
Pharma & Biotech
Save to list
Save to list
Interview: CD34+ Cells in Cell and Gene Therapy Process Development
Download Document
CD34+ Cells for Cell and Gene Therapy Process Development
In this interview Dr. Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade CD34+ cells for cell and gene therapy process development. Please register to read.In this interview Dr. Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using our research-grade CD34+ cells for cell and gene therapy process development.
Dr. Destalminil explains
- how using commercially available CD34+ cells helped CellProthera optimize their process and save crucial patient samples
- why researchers should use mobilized CD34+ cells as opposed to other conventions
- what characteristics are needed when using frozen cells
- which advancements she would most like to see in this space Register to read or download the interview now.
Register now to read or download the interview.
Would you like to receive updates? Subscribe to our cell and gene therapy eNews to stay tuned on new educational content or product and applications news.
Would you like to learn more about our CD34+ cells or our broad portfolio of blood and immune cells and tissues?